Medically reviewed by Doru Paul, MD Key Takeaways Survival rates for stage 3 lung cancer can vary between 13% to 36% depending on the subtype.Stage 3a lung cancer is often treated with surgery and ...
Survival of patients with anal adenocarcinoma in comparison to rectal adenocarcinoma: A perspective from the United States National Cancer Database. Overall mortality, mean survival time, and landmark ...
Small cell lung cancer (SCLC) is a fast-growing cancer that forms in the lung. It's one of two types of lung cancer. The other type is non-small cell lung cancer (NSCLC). SCLC is less common than ...
NLR: neutrophil-to-lymphocyte ratio, dNLR: derived neutrophil-to-lymphocyte ratio, PLR: Platelet-to-lymphocyte ratio, MLR: Monocyte-to-lymphocyte ratio, SII: Systemic-immune-inflammation index, SIRI: ...
Ateganosine combined with Libtayo shows improved progression-free survival in advanced non-small cell lung cancer, suggesting potential long-term use. Spevatamig, a bispecific antibody, is being ...